Home >> Research Area >>Chromatin/Epigenetics>>Pim>> PIM-1 Inhibitor 2

PIM-1 Inhibitor 2

Potent Pim-1 kinase inhibitor CAS# 477845-12-8

PIM-1 Inhibitor 2

Catalog No. BCC2446----Order now to get a substantial discount!

Product Name & Size Price Stock
PIM-1 Inhibitor 2: 5mg $92 In Stock
PIM-1 Inhibitor 2: 10mg Please Inquire In Stock
PIM-1 Inhibitor 2: 20mg Please Inquire Please Inquire
PIM-1 Inhibitor 2: 50mg Please Inquire Please Inquire
PIM-1 Inhibitor 2: 100mg Please Inquire Please Inquire
PIM-1 Inhibitor 2: 200mg Please Inquire Please Inquire
PIM-1 Inhibitor 2: 500mg Please Inquire Please Inquire
PIM-1 Inhibitor 2: 1000mg Please Inquire Please Inquire
Related Products
  • IPI-145 (INK1197)

    Catalog No.:BCC1104
    CAS No.:1201438-56-3
  • IC-87114

    Catalog No.:BCC1161
    CAS No.:371242-69-2
  • PI-103

    Catalog No.:BCC1162
    CAS No.:371935-74-9
  • PIK-75

    Catalog No.:BCC1163
    CAS No.:372196-77-5
  • TGX-221

    Catalog No.:BCC1244
    CAS No.:663619-89-4

Quality Control of PIM-1 Inhibitor 2

Number of papers citing our products

Chemical structure

PIM-1 Inhibitor 2

3D structure

Chemical Properties of PIM-1 Inhibitor 2

Cas No. 477845-12-8 SDF Download SDF
PubChem ID 2765355 Appearance Powder
Formula C17H11CIN4O M.Wt 426.2
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 75 mM in DMSO
Chemical Name 4-[3-(4-chlorophenyl)-2,1-benzoxazol-5-yl]pyrimidin-2-amine
SMILES C1=CC(=CC=C1C2=C3C=C(C=CC3=NO2)C4=NC(=NC=C4)N)Cl
Standard InChIKey AQVFETGXIRKVAQ-UHFFFAOYSA-N
Standard InChI InChI=1S/C17H11ClN4O/c18-12-4-1-10(2-5-12)16-13-9-11(3-6-15(13)22-23-16)14-7-8-20-17(19)21-14/h1-9H,(H2,19,20,21)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of PIM-1 Inhibitor 2

DescriptionPotent Pim-1 kinase inhibitor (Ki = 91 nM).

PIM-1 Inhibitor 2 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

PIM-1 Inhibitor 2 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of PIM-1 Inhibitor 2

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.3463 mL 11.7316 mL 23.4632 mL 46.9263 mL 58.6579 mL
5 mM 0.4693 mL 2.3463 mL 4.6926 mL 9.3853 mL 11.7316 mL
10 mM 0.2346 mL 1.1732 mL 2.3463 mL 4.6926 mL 5.8658 mL
50 mM 0.0469 mL 0.2346 mL 0.4693 mL 0.9385 mL 1.1732 mL
100 mM 0.0235 mL 0.1173 mL 0.2346 mL 0.4693 mL 0.5866 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on PIM-1 Inhibitor 2

Potent Pim-1 kinase inhibitor (Ki = 91 nM).

Featured Products
New Products
 

References on PIM-1 Inhibitor 2

Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)- 5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.[Pubmed:26505898]

J Med Chem. 2015 Nov 12;58(21):8373-86.

Pan proviral insertion site of Moloney murine leukemia (PIM) 1, 2, and 3 kinase inhibitors have recently begun to be tested in humans to assess whether pan PIM kinase inhibition may provide benefit to cancer patients. Herein, the synthesis, in vitro activity, in vivo activity in an acute myeloid leukemia xenograft model, and preclinical profile of the potent and selective pan PIM kinase inhibitor compound 8 (PIM447) are described. Starting from the reported aminopiperidyl pan PIM kinase inhibitor compound 3, a strategy to improve the microsomal stability was pursued resulting in the identification of potent aminocyclohexyl pan PIM inhibitors with high metabolic stability. From this aminocyclohexyl series, compound 8 entered the clinic in 2012 in multiple myeloma patients and is currently in several phase 1 trials of cancer patients with hematological malignancies.

Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.[Pubmed:18290603]

J Med Chem. 2008 Mar 27;51(6):1972-5.

To supplement the hits from a high throughput screen, docking was performed against Pim-1 kinase. Glide docking was augmented with a filter to require traditional or aromatic CH..O hydrogen bonds to the kinase hinge. Four diverse actives, of 96 molecules assayed, had K(i) values between 0.091 and 4.5 microM. This gives a 14-fold enrichment over the earlier HTS run, and the two crystal structures solved confirmed the binding modes predicted by docking.

Description

Pim-1 kinase inhibitor

Keywords:

PIM-1 Inhibitor 2,477845-12-8,Natural Products,Pim, buy PIM-1 Inhibitor 2 , PIM-1 Inhibitor 2 supplier , purchase PIM-1 Inhibitor 2 , PIM-1 Inhibitor 2 cost , PIM-1 Inhibitor 2 manufacturer , order PIM-1 Inhibitor 2 , high purity PIM-1 Inhibitor 2

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: